114 related articles for article (PubMed ID: 11566350)
1. Chronic T-cell lymphoproliferative disease expressing natural killer cell receptors: clinicopathological and molecular features.
Kwong YL; Lam CC; Choy C; Man C; Au WY; Siu LL
Cancer Genet Cytogenet; 2001 Sep; 129(2):168-72. PubMed ID: 11566350
[TBL] [Abstract][Full Text] [Related]
2. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type.
Hoffmann T; De Libero G; Colonna M; Wodnar-Filipowicz A; Passweg J; Favre G; Gratwohl A; Tichelli A
Br J Haematol; 2000 Sep; 110(3):525-36. PubMed ID: 10997961
[TBL] [Abstract][Full Text] [Related]
3. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
5. Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy.
Olteanu H; Schur BC; Bredeson C; Atallah E; Kroft SH
Leuk Lymphoma; 2010 Mar; 51(3):481-7. PubMed ID: 20141431
[TBL] [Abstract][Full Text] [Related]
6. Study of the major phenotype of large granular T-cell lymphoproliferative disorder.
Sun T; Brody J; Koduru P; Vinciguerra V; Weiselberg L; Marino J; Chaudhri F; Papps J; Erickson R
Am J Clin Pathol; 1992 Nov; 98(5):516-21. PubMed ID: 1283056
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia.
Morice WG; Kurtin PJ; Leibson PJ; Tefferi A; Hanson CA
Br J Haematol; 2003 Mar; 120(6):1026-36. PubMed ID: 12648073
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality.
Bárcena P; Jara-Acevedo M; Tabernero MD; López A; Sánchez ML; García-Montero AC; Muñoz-García N; Vidriales MB; Paiva A; Lecrevisse Q; Lima M; Langerak AW; Böttcher S; van Dongen JJ; Orfao A; Almeida J
Oncotarget; 2015 Dec; 6(40):42938-51. PubMed ID: 26556869
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
Kurt H; Jorgensen JL; Amin HM; Patel KP; Wang SA; Lin P; Kanagal-Shamanna R; Loghavi S; Thakral B; Khogeer HA; Jabbour EJ; Li S; Yin CC; Medeiros LJ; Khoury JD
Eur J Haematol; 2018 May; 100(5):444-454. PubMed ID: 29385279
[TBL] [Abstract][Full Text] [Related]
11. Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis.
Kwong YL; Lam CC; Chan TM
Br J Haematol; 2000 Jul; 110(1):197-202. PubMed ID: 10930998
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic Expression of CD3ε Heterodimers by Flow Cytometry Rapidly Distinguishes Between Mature T-Cell and Natural Killer-Cell Neoplasms.
Shi M; Nguyen P; Timm MM; Otteson GE; Horna P; Olteanu H; Jevremovic D
Am J Clin Pathol; 2020 Oct; 154(5):683-691. PubMed ID: 32589191
[TBL] [Abstract][Full Text] [Related]
13. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
14. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder.
Magro C; Crowson AN; Kovatich A; Burns F
Hum Pathol; 2002 Aug; 33(8):788-95. PubMed ID: 12203210
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease].
Zhang Q; Zhang HY; Zhang WL; Zhong FL; Feng J; Meng QX; Yin WH; Nie LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):953-7. PubMed ID: 23998592
[TBL] [Abstract][Full Text] [Related]
17. The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferations.
de Mel S; Li JB; Abid MB; Tang T; Tay HM; Ting WC; Poon LM; Chung TH; Mow B; Tso A; Ong KH; Chng WJ; Liu TC
Cytometry B Clin Cytom; 2018 Jan; 94(1):159-168. PubMed ID: 28431200
[TBL] [Abstract][Full Text] [Related]
18. Natural killer and natural killer-T cells in psoriasis.
Cameron AL; Kirby B; Fei W; Griffiths CE
Arch Dermatol Res; 2002 Nov; 294(8):363-9. PubMed ID: 12420105
[TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
Nichols GE; Normansell DE; Williams ME
Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
[TBL] [Abstract][Full Text] [Related]
20. [Aggressive natural killer cell lymphoproliferative disease of large granular lymphocytes with leukemia-like clinical course in the terminalstage].
Tsukada T; Ohno T; Morita K; Otsuji H; Sekine T; Nishikawa M; Kobayashi T; Kita K; Shirakawa S; Namba K
Rinsho Ketsueki; 1991 Feb; 32(2):162-6. PubMed ID: 2027242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
